According to Sanofi latest financial reports the cash on hand of SAN is $422.07B, an increase of 50.03% to 2022. At the end of 2022 company had $281.33B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $422.07B | 50.03% |
2022 | $281.33B | 2.56% |
2021 | $274.32B | 38.26% |
2020 | $198.40B | -23.54% |
2019 | $259.47B | -3.83% |
2018 | $269.79B | - |